San Diego, CA – January 7, 2019 – Objective Capital Partners, a leading M&A investment banking firm providing M&A, Corporate Development, and Valuation Advisory Services, is pleased to announce that Managing Director David H. Crean, MBA, Ph.D, has been named a San Diego Top 500 Most Influential Business Leader by the San Diego Business Journal. The list of honorees represents those business leaders in San Diego that are influential, have built and lead successful companies and stand apart for their unique roles in building the San Diego business community. The SD 500 List is sponsored by the San Diego Business Journal and includes leaders in a wide range of industries including business services, finance, health & science, technology, wealth & investments and icons in the community.
The San Diego 500, The Book of Influential Business Leaders, 2020, is the market’s most comprehensive listing of business community leaders in the San Diego area and is chosen on editorial merit alone. The list, selected by the San Diego Business Journal newsroom, includes executives and experts in their field, who have established, or are currently managing, significant companies. The List of Influential Business Leaders was originally published in 2016 to serve the community with local market intelligence on which business professionals to be aware of in each industry.
“I am thankful to be included in this list of innovators, deal makers, and business leaders,” stated David Crean. “To be recognized as one of the top professionals across all industries in San Diego is a true honor. I look forward to continuing to drive growth in the new year.”
David H. Crean has been named an influential leader within the Finance category due to his over 25 years of life sciences R&D and corporate development transactional experience in the pharmaceutical industry responsible for leading mergers, acquisitions, licensing and collaborations, and establishing corporate strategy. Mr. Crean currently operates as a Managing Director at Objective Capital Partners where he leads the firm’s M&A, partnering, strategic advisory and capital financing transactions with life science and healthcare clients.
To read the full list in the SDBJ, visit: http://sdbusinessjournal.pressreader.com/san-diego-business-journal/20191216.
For Immediate Inquiry:
Marketing Operations Manager
The above testimonials may not be representative of the experience of other customers and is not a guarantee of future performance or success.
This news release is for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC make no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. All information contained herein is preliminary, limited and subject to completion, correction or amendment. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person. Securities and investment banking services are offered through BA Securities, LLC Member FINRA, SIPC. Principals of Objective Capital are Registered Representatives of BA Securities. Objective Capital Partners and BA Securities are separate and unaffiliated entities.